BCRX, BioCryst Pharmaceuticals and Reports Q1 Loss
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a first-quarter earnings loss of $(0.17) per share versus the consensus estimate loss of $(0.21) per share and $(0.28) reported a year ago. BioCryst Pharma reported sales of $92.
VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
VRTX stock results show that Vertex Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires.
BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.
Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The ...
A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit ...
Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease ...
The Department of Pharmaceuticals (DoP) is planning to hire professionals as consultants to manage the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, announced last ...
The cystic fibrosis leader reported higher-than-expected earnings and revenue.
By Paul Ziobro Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of ...
Investors might want to bet on Rocket Pharmaceuticals (NASDAQ: RCKT), as it has been recently upgraded to a Zacks Rank #2 ...
CRANBURY, N.J. (AP) — CRANBURY, N.J. (AP) — Rocket Pharmaceuticals Inc. (RCKT) on Monday reported a loss of $62.1 million in its first quarter. The Cranbury, New Jersey-based company said it had a ...
By Chris Wack NRx Pharmaceuticals shares were up 38% to $2.90 after the company said it saw a statistically significant safety advantage of NRX-101 ...
WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $31.2 million in its fiscal second quarter. The Watertown, Massachusetts-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback